市场调查报告书
商品编码
1399708
调强放射治疗市场-放射类型(质子、电子、光子、碳离子)、应用(前列腺癌、肺癌、乳腺癌、脑癌和妇科癌症)、最终用途(医院、独立放射治疗中心)-全球预测, 2023年- 2032Intensity Modulated Radiation Therapy Market-Radiation Type (Proton, Electron, Photon, Carbon-ion), Application (Prostate, Lung, Breast, Brain & Gynecological Cancer), End use (Hospital, Standalone Radiation Therapy Center)-Global Forecast, 2023-2032 |
预计从 2023 年到 2032 年,调强放射治疗市场规模将扩大 5.2%。全球癌症发生率不断上升,推动了对先进、精准治疗方法的需求。调强放射治疗提高了标靶肿瘤的准确性,同时最大限度地减少对周围健康组织的损害,从而使其广泛采用。例如,2023 年 10 月,UT Health San Antonio 推出了 Pluvicto,这是一种 FDA 批准的放射性药物,专门针对前列腺特异性膜抗原阳性 (PSMA+) 转移性去势抵抗性前列腺癌提供放射治疗。
政府支持性倡议的涌入、医疗保健基础设施投资的增加以及创新放射治疗解决方案的不断开发正在满足癌症患者和医疗保健提供者不断变化的需求。此外,人们对调强放射治疗 (IMRT) 益处的认识不断提高,例如减少副作用和改善治疗结果,将推动产业成长。
调强放射治疗市场分为放射类型、应用、最终用途和区域。
预计从 2023 年到 2032 年,电子放射治疗领域的行业份额将以 5.3% 的CAGR增长。这一增长归因于电子放射治疗表浅肿瘤的精确性和有效性。这种方式提供了改进的靶向性并最大限度地减少对周围健康组织的损害。对先进和标靶癌症治疗的需求不断增长也将推动该领域的成长。
根据应用情况,妇科癌症领域的调强放射治疗市场规模预计在 2023 年至 2032 年期间CAGR为 5.1%。这归因于妇科癌症发病率的增加、对精确和有针对性的放射治疗的高需求以及治疗计划的进步。 IMRT 能够在不伤害健康组织的情况下提供聚焦辐射,这也将有助于其用于治疗妇科癌症。
从区域来看,亚太调强放射治疗市场预计从 2023 年到 2032 年将以 5.8% 的CAGR扩张。这是由于癌症患病率不断上升、对先进治疗方案的认识不断提高以及医疗保健基础设施的改善。尖端技术的采用、政府措施的增加以及对个人化癌症护理不断增长的需求也将促进区域市场的扩张。
Intensity modulated radiation therapy market size is projected to expand at 5.2% from 2023 to 2032. The increasing incidence of cancer globally is fueling the demand for advanced and precise treatment methods. Intensity modulated radiation therapy offers enhanced accuracy in targeting tumors while minimizing damages to surrounding healthy tissues, leading to its widespread adoption. For instance, in October 2023, UT health San Antonio launched Pluvicto, an FDA-approved radiopharmaceutical to provide radiation treatment therapy specifically to prostate-specific membrane antigen positive (PSMA+) metastatic castration-resistant prostate cancer.
The influx of supportive government initiatives, rising investments in healthcare infrastructure, and the continuous development of innovative radiation therapy solutions are catering to the evolving needs of cancer patients and healthcare providers. Additionally, the rising awareness of the benefits of intensity modulated radiation therapy (IMRT), such as reduced side effects and improved treatment outcomes, will fuel the industry growth.
The intensity modulated radiation therapy market is segregated into radiation type, application, end-use, and region.
The industry share from the electron radiation therapy segment is projected to rise at 5.3% CAGR from 2023 to 2032. The growth is attributed to the precision and effectiveness of electron radiation in treating superficial tumors. This modality offers improved targeting and minimizes damages to the surrounding healthy tissues. The growing demand for advanced and targeted cancer treatments will also drive the segment growth.
Based on application, the intensity modulated radiation therapy market size from the gynecological cancer segment is projected to depict 5.1% CAGR during 2023-2032. This is ascribed to the increasing incidence of gynecological cancers, high demand for precise and targeted radiation therapy, and the advancements in treatment planning. The ability of IMRT to deliver focused radiation while sparing healthy tissues will also contribute to its adoption for treating gynecological cancers.
Regionally, the Asia Pacific intensity modulated radiation therapy market is projected to expand at 5.8% CAGR from 2023 to 2032. This is due to the increasing prevalence of cancer, rising awareness of advanced treatment options, and the improving healthcare infrastructure. The adoption of cutting-edge technologies, the increasing government initiatives, and the growing demand for personalized cancer care will also boost the regional market expansion.